The New Hunger Games:  GLP Lawsuits

The New Hunger Games:  GLP Lawsuits

We expected miracles—what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a growing swarm of lawsuits threatens to upend the billion-dollar industry. Are patients being blindsided—or is this just the next chapter in America's pharmaceutical blame game?

GLP Posts $1.8B Loss on China Asset Markdowns - Mingtiandi

GLP swung to an annual loss of $1.8 billion on China asset markdowns and other non-cash items, but the Asian warehouse specialist touted improved cash flows and hinted at a turnaround following the March sale of its international funds business... Read More>> The post GLP Posts $1.8B Loss, Looks to Right Ship After Sale of International Funds Business appeared first on Mingtiandi.